[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO981356D0 - Tiofenpyrimidiner - Google Patents

Tiofenpyrimidiner

Info

Publication number
NO981356D0
NO981356D0 NO981356A NO981356A NO981356D0 NO 981356 D0 NO981356 D0 NO 981356D0 NO 981356 A NO981356 A NO 981356A NO 981356 A NO981356 A NO 981356A NO 981356 D0 NO981356 D0 NO 981356D0
Authority
NO
Norway
Prior art keywords
tiofenpyrimidiner
Prior art date
Application number
NO981356A
Other languages
English (en)
Other versions
NO981356L (no
Inventor
Chen Chen
James R Mccarthy
Thomas R Webb
Terence J Moran
Original Assignee
Janssen Pharmaceutica Nv
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv, Neurocrine Biosciences Inc filed Critical Janssen Pharmaceutica Nv
Publication of NO981356D0 publication Critical patent/NO981356D0/no
Publication of NO981356L publication Critical patent/NO981356L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO981356A 1996-02-07 1998-03-25 Tiofenpyrimidiner NO981356L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1127496P 1996-02-07 1996-02-07
US2768996P 1996-10-08 1996-10-08
PCT/EP1997/000457 WO1997029110A1 (en) 1996-02-07 1997-01-30 Thiophenopyrimidines

Publications (2)

Publication Number Publication Date
NO981356D0 true NO981356D0 (no) 1998-03-25
NO981356L NO981356L (no) 1998-07-09

Family

ID=26682201

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981356A NO981356L (no) 1996-02-07 1998-03-25 Tiofenpyrimidiner

Country Status (17)

Country Link
US (2) US6255310B1 (no)
EP (1) EP0882051B1 (no)
JP (1) JP2000504678A (no)
KR (1) KR19990067390A (no)
AR (1) AR005731A1 (no)
AT (1) ATE208395T1 (no)
CA (1) CA2233307A1 (no)
DE (1) DE69708059T2 (no)
DK (1) DK0882051T3 (no)
ES (1) ES2167710T3 (no)
ID (1) ID15904A (no)
MY (1) MY119118A (no)
NO (1) NO981356L (no)
NZ (1) NZ330118A (no)
PT (1) PT882051E (no)
TW (1) TW448178B (no)
WO (1) WO1997029110A1 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
KR100446363B1 (ko) 1997-11-11 2004-09-01 화이자 프로덕츠 인코포레이티드 항암제로 유용한 티에노피리미딘 및 티에노피리딘 유도체
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
DE19837387A1 (de) * 1998-08-18 2000-02-24 Aventis Res & Tech Gmbh & Co 3'-Desoxypentopyranosyl-Nucleinsäure, ihre Herstellung und Verwendung
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
OA12050A (en) 1999-09-30 2006-05-02 Neurogen Corp Certain alkylene diamine-substituted heterocycles.
IL139197A0 (en) 1999-10-29 2001-11-25 Pfizer Prod Inc Use of corticotropin releasing factor antagonists and related compositions
TWI271406B (en) 1999-12-13 2007-01-21 Eisai Co Ltd Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
ATE277933T1 (de) 2000-06-06 2004-10-15 Pfizer Prod Inc Thiophenverbindungen zur verwendung als antikrebsmittel
US6503914B1 (en) 2000-10-23 2003-01-07 Board Of Regents, The University Of Texas System Thienopyrimidine-based inhibitors of the Src family
TWI312347B (en) 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
ES2366082T3 (es) 2001-04-27 2011-10-17 EISAI R&D MANAGEMENT CO., LTD. Pirazolo 1,5-a piridinas y medicinas que las contienen.
US7285557B2 (en) * 2001-10-15 2007-10-23 Smithkline Beecham P.L.C. Pyrimidinones as melanin concentrating hormone receptor 1
US6872827B2 (en) 2002-04-26 2005-03-29 Chembridge Research Laboratories, Inc. Somatostatin analogue compounds
US20100189797A1 (en) 2002-06-10 2010-07-29 Julien Mendlewicz Oral antidepressant formulation
US7671047B2 (en) * 2002-06-19 2010-03-02 Sanofi-Aventis Deutschland Gmbh Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
US7176216B2 (en) 2002-10-22 2007-02-13 Eisai Co., Ltd. 7-phenylpyrazolopyridine compounds
NZ538860A (en) 2002-10-22 2006-07-28 Eisai Co Ltd 7-Phenyl pyrazolopyridine compounds
US20050001673A1 (en) * 2002-10-29 2005-01-06 Zvi Regev Direct digital frequency modulation / phase modulation decoder
US20060071832A1 (en) * 2002-10-29 2006-04-06 Zvi Regev Instantaneous phase digitizer
US20060024661A1 (en) * 2003-07-30 2006-02-02 The Regents Of The University Of California Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
RU2006128580A (ru) 2004-01-06 2008-02-20 Тайсо Фармасьютикал Ко., Лтд. (Jp) Производные тиенопиримидина и тиенопиридина, замещенные циклической аминогруппой
JP4742273B2 (ja) 2004-01-06 2011-08-10 大正製薬株式会社 ピロロピリミジン及びピロロトリアジン誘導体
CN1980957A (zh) 2004-03-23 2007-06-13 比奥根艾迪克Ma公司 受体偶联剂及其治疗用途
EP1766014A4 (en) 2004-06-03 2008-12-10 Athlomics Pty Ltd AGENTS AND METHODS FOR THE DIAGNOSIS OF STRESS
JP2007161585A (ja) 2004-06-25 2007-06-28 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
EP1814561A4 (en) 2004-10-29 2012-12-19 Biocryst Pharm Inc THEROPUTICAL FUROPYRIMIDINES AND THIENOPYRIMIDINES
EP1863500A2 (en) 2005-03-29 2007-12-12 Biocryst Pharmaceuticals, Inc. Hepatitis c therapies
WO2008082839A2 (en) * 2006-12-29 2008-07-10 Abbott Laboratories Pim kinase inhibitors as cancer chemotherapeutics
SI2266990T1 (sl) 2008-04-15 2013-01-31 Eisai R&D Management Co. Ltd. Spojina 3-fenilpirazolo(5,1-b)tiazola
AR078521A1 (es) 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
WO2017047090A1 (ja) 2015-09-18 2017-03-23 日本電気株式会社 指紋撮像システム、指紋撮像装置、画像処理装置、指紋撮像方法、及び記録媒体
WO2017112777A1 (en) 2015-12-22 2017-06-29 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
CN111032662B (zh) 2017-06-21 2024-10-15 尚医治疗有限责任公司 与ras超家族相互作用的用于治疗癌症、炎性疾病、ras蛋白病和纤维化疾病的化合物
CN110590807B (zh) * 2019-10-09 2022-01-07 陕西理工大学 一种噻吩并[3,2-d]嘧啶类衍生物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2121950A1 (en) 1971-05-04 1972-11-23 Dr. Karl Thomae Gmbh, 7950 Biberach Thieno(3,2-d)pyrimidine derivs - with thrombocyte aggregation inhibiting activity
EP0071227B1 (en) * 1981-07-31 1987-11-11 Sloan-Kettering Institute For Cancer Research Anti-leukemic beta-glycosyl c-nucleosides
US5063245A (en) * 1990-03-28 1991-11-05 Nova Pharmaceutical Corporation Corticotropin-releasing factor antagonism compounds
AU651337B2 (en) * 1990-03-30 1994-07-21 Dowelanco Thienopyrimidine derivatives
DE69323768T2 (de) * 1992-12-17 1999-07-01 Pfizer Inc., New York, N.Y. Pyrrolopyrimidine als crf antagonisten
TW444018B (en) 1992-12-17 2001-07-01 Pfizer Pyrazolopyrimidines
TW574214B (en) * 1994-06-08 2004-02-01 Pfizer Corticotropin releasing factor antagonists
DE69603240T2 (de) * 1995-05-12 2000-01-05 Neurogen Corp., Branford Neue deazapurinderivate; eine neue klasse von crf1-spezifischen liganden

Also Published As

Publication number Publication date
AR005731A1 (es) 1999-07-14
DE69708059D1 (en) 2001-12-13
AU725674B2 (en) 2000-10-19
AU1720997A (en) 1997-08-28
EP0882051B1 (en) 2001-11-07
US6255310B1 (en) 2001-07-03
WO1997029110A1 (en) 1997-08-14
JP2000504678A (ja) 2000-04-18
DK0882051T3 (da) 2002-02-25
TW448178B (en) 2001-08-01
ID15904A (id) 1997-08-14
ES2167710T3 (es) 2002-05-16
NO981356L (no) 1998-07-09
MY119118A (en) 2005-03-31
DE69708059T2 (de) 2002-07-18
EP0882051A1 (en) 1998-12-09
ATE208395T1 (de) 2001-11-15
CA2233307A1 (en) 1997-08-14
KR19990067390A (ko) 1999-08-16
NZ330118A (en) 2000-03-27
PT882051E (pt) 2002-04-29
US20020052362A1 (en) 2002-05-02
US6469166B2 (en) 2002-10-22

Similar Documents

Publication Publication Date Title
BR9703884A (pt) Cicloalcanopiridinas
ATE208395T1 (de) Thiophenopyrimidine
BR9704464A (pt) Evisceradora
ATE262512T1 (de) Arylalkanoylpyridazine
ATE208773T1 (de) Chinoxalindione
DE59609702D1 (de) Pulversprüheinrichtung
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
BR9703563A (pt) Hidromancal
BR9703835A (pt) Hidromancal
BR9707467A (pt) 1-Pirazol-3-iletil-4-indol-3-ilpiperdinas
DE59706319D1 (de) Carbamoylcarbonsäureamidoxime
BR9708716A (pt) 3-cianoaril-pirazóis
NO985310D0 (no) HÕndteringsinnretning
ATE267568T1 (de) Epithese
DE59610630D1 (de) Paradontalsonde
ITSS960001A1 (it) Giolux
BR7602320U (pt) Supedânea
BR7600260U (pt) Multi-morsa
BR7600429U (pt) Hidrolax
FI960898A0 (fi) Renborstande hoensnaeste
FI963035A0 (fi) Provtagningsinstrument
FIU960164U0 (fi) Puuliitos
BR7601926U (pt) Sofá-mesa
BR7601419U (pt) Mourao
BR7601720U (pt) Paraglayder

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application